| 0 | ℹ |
RNA terminal uridylyl transferases are druggable vulnerabilities in AML but are dispensable for normal hematopoiesis.
(science.org)
|
Science Advances 2026-08-12 | #leukemia #hematopoiesis #drug target #apoptosis | |
| 0 | ℹ |
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia.
(nature.com)
|
Nature Cancer 2026-08-12 | #immunotherapy #leukemia #amr #nanoparticles #transcriptomics | |
| 0 | ℹ |
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.
(science.org)
|
Science Translational Medicine 2026-08-12 | #p53 #leukemia #methylation #immunotherapy #mutagenesis |